Veeva Systems \ Solutions \ Primary Care Sales

By: Veeva Systems  11-11-2011
Keywords: CRM

The pharmaceutical landscape changes quickly. Unfortunately for the majority of primary care sales organizations today, their Pharma CRM tools have not been able to change with the market. These traditional solutions have become much too inflexible and too costly to maintain, leaving pharmaceutical companies in the unenviable position of overspending every day on solutions that no longer meet their business requirements.

The Veeva CRM suite satisfies the demand for a more flexible, cost effective, and easy to use solution for managing primary care sales forces. combines detailed physician and account management, call planning and scheduling, samples management, and fast call reporting with visual intelligence to provide users with the most intuitive CRM solution on the market. And all of this comes in the industry's solution for 21 CFR Part 11 and PDMA compliance. Finally, flexibility and simplicity reach new heights with our , , and even capabilities. To find out how many organizations have already made the , to view a and to answer your own “What if you could?” question, we invite you to explore our site further or anytime.

Keywords: CRM

Other products and services from Veeva Systems

11-11-2011

Veeva Systems \ Solutions \ Specialty Care Sales

As the era of blockbuster drugs fades, most new approved medications are specialty products such as injected and infused drugs, administered in hospitals, clinics, and physician offices. Marketing and selling these specialty products is fundamentally different than selling traditional medications through the retail pharmacy channel.


11-11-2011

Veeva Systems \ iRep

By bringing together elegant CRM functionality with streamlined CLM capabilities on the iPad, Veeva is delivering a completely new user experience, so much improved that it actually improves the quality of customer interactions. IRep is the first truly integrated CRM + CLM solution designed specifically for the iPad and marks the start of a new race to gain competitive advantage in the pharma industry.